Inserts Containing Combination Therapy May Protect Women Against HIV – APhA submits compounding comments to FDA. – (866) 348-2889.
Vaginal inserts containing tenofovir alafenamide fumarate (TAF) in combination with elvitegravir (EVG) may help protect women against HIV infection.
Data compiled from a recent study showed that this therapy was highly effective in preventing simian/HIV (SHIV) infection in a macaque model mimicking vaginal transmission of HIV. 1
Results of the study were presented last week at the Conference on Retroviruses and Opportunistic Infections in Seattle, Washington.